Guidance in Clinical Research in Argentina

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Guidance in Clinical Research in Argentina

Guidance in Clinical Research in Argentina – Clinical Trials Landscape in LATAM

Argentina, a country known for its rich cultural heritage and vibrant society, also boasts a robust healthcare system and a growing interest in clinical research. Conducting clinical research in Argentina presents unique opportunities for researchers to contribute to medical knowledge and make a positive impact on public health outcomes.

In this blog, we will explore the essential aspects of guidance in clinical research in Argentina, including its regulatory framework, ethical considerations, research infrastructure, and emerging trends. By understanding the nuances of clinical research in Argentina, researchers can navigate the landscape more effectively and participate in advancing the nation’s healthcare development.

Regulatory Framework for Clinical Research

Clinical research in Argentina is regulated by the Administración Nacional de Medicamentos, Alimentos y Tecnología Médica (ANMAT) and the Comité Independiente de Ética para Ensayos en Farmacología Clínica (CIEFAC). ANMAT is responsible for evaluating and approving clinical trials involving drugs, medical devices, and other healthcare products to ensure safety, efficacy, and quality. Researchers must submit comprehensive study protocols and relevant documentation to ANMAT for approval before initiating their research.

CIEFAC oversees the ethical aspects of clinical research in Argentina. All research involving human participants must undergo ethical review and receive approval from accredited ethics committees (ECs). These ECs comprise multidisciplinary experts who carefully assess the scientific validity, participant safety, and informed consent process of the proposed research.

Argentina has made significant strides in harmonizing its regulatory requirements with international standards, including adherence to Good Clinical Practice (GCP) guidelines set by the International Conference on Harmonisation (ICH). This alignment facilitates collaborations with international partners and enhances the credibility of research conducted in the country.

Ethical Considerations in Clinical Research

Respecting the rights and welfare of research participants is of utmost importance in clinical research in Argentina. The informed consent process holds a central place in upholding ethical principles, and researchers must ensure that participants fully comprehend the study’s objectives, potential risks, benefits, and their rights before providing informed consent.

Moreover, researchers should be mindful of the cultural context of Argentina, which is home to diverse ethnic groups and communities. Culturally sensitive approaches and inclusive research practices are vital for building trust with local communities and ensuring their engagement in the research process.

Additionally, international researchers collaborating with Argentine counterparts should familiarize themselves with local cultural norms and language to enhance communication and foster mutual respect during the research endeavor.

Guidance in Clinical Research in Argentina

Guidance in Clinical Research in Argentina

Guidance in Clinical Research in Argentina

Research Infrastructure and Capabilities

Argentina boasts a well-established research infrastructure with numerous academic institutions, hospitals, and research centers. Major cities like Buenos Aires, Córdoba, and Rosario serve as significant hubs for clinical research, providing access to a diverse patient population and specialized medical expertise.

The Argentine government, through agencies like the Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET) and the Agencia Nacional de Promoción de la Investigación, el Desarrollo Tecnológico y la Innovación (ANPI), invests in research and development initiatives. These investments contribute to the growth of clinical research capabilities and foster the development of innovative healthcare technologies and treatments.

Argentine researchers have made noteworthy contributions to various medical fields, including oncology, cardiology, infectious diseases, and neurology. Their expertise and experience in addressing healthcare challenges unique to Argentina provide valuable opportunities for collaboration and knowledge exchange for researchers worldwide.

Emerging Trends in Clinical Research

Clinical research in Argentina reflects the country’s dynamic healthcare landscape and global health trends. Some notable emerging trends include:

  1. Personalized Medicine: Argentina is embracing personalized medicine, leveraging advances in genomic research to tailor treatments to individual patient characteristics. This approach has the potential to significantly improve treatment outcomes and patient satisfaction.
  2. Telemedicine and Digital Health: The COVID-19 pandemic accelerated the adoption of telemedicine and digital health solutions in Argentina. These technologies have revolutionized healthcare access and offer new avenues for conducting remote clinical research.
  3. Tropical and Vector-Borne Diseases: Given its geographic diversity, Argentina faces public health challenges related to tropical and vector-borne diseases. Researchers are focusing on studying and combating diseases like Chagas disease, dengue fever, and Zika virus to improve healthcare outcomes for affected populations.
  4. Vaccines and Immunology: Argentina remains actively involved in vaccine development and immunological research. Researchers collaborate with international partners to address global health concerns related to infectious diseases and pandemics.


Guidance in clinical research in Argentina entails navigating a complex landscape of regulations, ethical considerations, research infrastructure, and emerging trends. By prioritizing participant welfare, cultural sensitivity, and collaborative engagement with local researchers and communities, researchers can conduct successful and ethically sound clinical studies.

Argentina’s diverse healthcare landscape, robust research infrastructure, and supportive regulatory environment provide researchers with unique opportunities to make meaningful contributions to medical knowledge and improve healthcare outcomes for its population and beyond.

As researchers continue to leverage emerging trends in healthcare, such as personalized medicine and digital health solutions, they can actively shape the future of clinical research in Argentina and contribute to its transformation into a prominent player in global healthcare research.

Guidance in Clinical Research in Argentina

Source: World Courier

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Guidance in Clinical Research in Argentina

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
Guidance in Clinical Research in Argentina

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Guidance in Clinical Research in Argentina

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Guidance in Clinical Research in Argentina

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

Guidance in Clinical Research in Argentina

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

Guidance in Clinical Research in Argentina

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
Guidance in Clinical Research in Argentina

The Cohortias Team

Guidance in Clinical Research in Argentina

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Guidance in Clinical Research in Argentina

Network & Partnerships